Acurion Raises $4.3M Seed to Advance AI Precision Oncology
Funding led by TK Partners supports further clinical validation, regulatory preparation, and commercialization of OncoGaze™ Acurion, a precision oncology technology company advancing AI-driven cancer biomarker...